Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kefah Al-Hayk"'
Autor:
Raid M. Kofahi, Majdi Al Qawasmeh, Kefah Al-Hayk, Khalid El-Salem, Salma Y. Bashayreh, Abdel-Hameed Al-Mistarehi, Adel Bataineh, Ahmed Yassin
Publikováno v:
The American Journal of Case Reports
Patient: Female, 73-year-old Final Diagnosis: SIRPIDs Symptoms: Stimulus-induced jerks in the head and right arm • right gaze deviation Medication: Valproate • Carbamazepine • Clonazepam Clinical Procedure: Continuous video-electroencephalogram
Autor:
Basheer Khassawneh, Abdel-Hameed Al-Mistarehi, Salma Y. Bashayreh, Kefah Al-Hayk, Ahmed Yassin, Sumayyah K. Abumurad, Anas M Zein Alaabdin, Mohamad I Jarrah, Khalid El-Salem, Raid M. Kofahi, Majdi Al Qawasmeh, Duha Al-Shorafat, Mohammad G. Qasaimeh
Publikováno v:
Seizure. 89
Introduction : A single-lead electrocardiogram (EKG) is routinely recorded with electroencephalogram (EEG). This study investigates the frequency and types of EKG abnormalities during routine EEG. Methods : All routine EEGs (20–60 min) over one yea
Autor:
Raid M. Kofahi, Majdi Al Qawasmeh, Suhib Sabaheen, Khalid El-Salem, Aiman Momani, Kefah Al-Hayk, Hassan M. Kofahi, Ahmed Yassin
Publikováno v:
BMC Neurology
BMC Neurology, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Neurology, Vol 20, Iss 1, Pp 1-8 (2020)
Background Multiple sclerosis (MS) is a neurological disease that is caused by an autoimmune response that results in the neuron’s demyelination in the central nervous system. The exact etiology of MS is not clear; however, several environmental an
Autor:
Alham Al-Sharman, Abdel-Hameed Al-Mistarehi, Ahmed Yassin, Raid M. Kofahi, Salma Y. Bashayreh, Majdi Al Qawasmeh, Hanan Khalil, Kefah Al-Hayk, Khalid El-Salem, Ahmed Z. Obeidat
Publikováno v:
Multiple Sclerosis and Related Disorders. 48:102732
Vitamin D (Vit.D) deficiency is a risk factor for multiple sclerosis (MS) and correlates with its severity. Depression is also common in people with MS (PWMS). We aim to investigate Vit.D correlation with depression risk scores in PWMS.A cross-sectio
Publikováno v:
Current Treatment Options in Neurology. 16
Approximately 5-8 % of myasthenia gravis (MG) patients test positive for antibodies against muscle- specific tyrosine kinase (MuSK) receptors. Except in extremely rare reports, all are acetylcholine receptor (AChR) antibody-negative. While MuSK myast
Autor:
Kefah Al-Hayk, Tulio E. Bertorini
Publikováno v:
The neurologist. 13(4)
Background Uremia may be associated with various neurologic manifestations, particularly a polyneuropathy, but also with focal neuropathies such as carpal tunnel syndrome and shunt-related neuropathies. Myopathies can also be caused by uremia and its
Publikováno v:
Journal of neurology. 253(9)
To characterize the clinical, demographic and epidemiological features of multiple sclerosis (MS) in Jordan.Data for consecutive Jordanian patients, fulfilling the McDonald criteria for clinically definite and clinically probable MS, during the time
Autor:
Matthew N. Meriggioli, Janice M. Massey, Kefah Al-Hayk, B. Tucker-Lipscomb, Julie Rowin, Donald B. Sanders, Emma Ciafaloni
Publikováno v:
Neurology. 61(10)
The authors report a retrospective analysis of the use of mycophenolate mofetil (MyM) in 85 patients with autoimmune myasthenia gravis. The Myasthenia Gravis Foundation of America (MGFA) postintervention status (PIS) was used to characterize the trea
Autor:
Kefah Al-Hayk, Mark S. LeDoux
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 18(1)